Outcomes research: what is it and why does it matter?

Abstract

[1]  M. Weinberger,et al.  Measuring Quality, Outcomes, and Cost of Care using Large Databases. Proceedings of the 6th Regenstrief Conference. Marshall, Indiana, 4-6 September 1996. , 1997, Annals of internal medicine.

[2]  A. Gittelsohn,et al.  Small Area Variations in Health Care Delivery , 1973, Science.

[3]  J. Simes,et al.  Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. The LIPID Study Investigators. , 2000, Archives of internal medicine.

[4]  Ellwood Pm,et al.  Shattuck Lecture--outcomes management. A technology of patient experience. 1988. , 1997, Archives of pathology & laboratory medicine.

[5]  R. Deyo,et al.  Randomized trial comparing traditional Chinese medical acupuncture, therapeutic massage, and self-care education for chronic low back pain. , 2001, Archives of internal medicine.

[6]  P. Ellwood,et al.  Shattuck lecture--outcomes management. A technology of patient experience. , 1988, The New England journal of medicine.

[7]  M. Stafford.  Problems in pharmacoeconomic analyses. , 2000, JAMA.

[8]  F B ROGERS,et al.  Medical Subject Headings , 1948, Nature.

[9]  F. Sarasin.  Decision analysis and its application in clinical medicine. , 2001, European journal of obstetrics, gynecology, and reproductive biology.

[10]  J. Eisenberg.  Agency for Health Care Policy and Research. , 1999, Medical care.

[11]  B. McNeil,et al.  Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer. , 1981, The New England journal of medicine.

[12]  M. Tattersall,et al.  Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. , 1987, The New England journal of medicine.

[13]  C. Earle,et al.  Outcomes research in oncology: history, conceptual framework, and trends in the literature. , 2000, Journal of the National Cancer Institute.

[14]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[15]  A. Donabedian,et al.  The quality of care. How can it be assessed? , 1988, JAMA.

[16]  R. M. Shelton,et al.  Hospital use and mortality among Medicare beneficiaries in Boston and New Haven. , 1989, The New England journal of medicine.

[17]  P. Pronovost,et al.  A new learning environment: combining clinical research with quality improvement. , 1999, Journal of evaluation in clinical practice.

[18]  S. Hill,et al.  Problems in Pharmacoeconomic Analyses—Reply , 2000 .

[19]  R H Brook,et al.  Does inappropriate use explain geographic variations in the use of health care services? A study of three procedures. , 1987, JAMA.

[20]  C. McHorney,et al.  Generic Health Measurement: Past Accomplishments and a Measurement Paradigm for the 21st Century , 1997, Annals of Internal Medicine.

[21]  D. Tulsky,et al.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  A M Epstein,et al.  Rolling down the runway: the challenges ahead for quality report cards. , 1998, JAMA.

[23]  E L Hannan,et al.  Benefits and hazards of reporting medical outcomes publicly. , 1996, The New England journal of medicine.

[24]  F. Davidoff,et al.  Patient-Centered Medicine: A Professional Evolution , 1996 .

[25]  A. Relman.  Assessment and Accountability: The Third Revolution in Medical Care , 1991, The New England journal of medicine.

[26]  W L Roper,et al.  Effectiveness in health care. An initiative to evaluate and improve medical practice. , 1988, The New England journal of medicine.

[27]  J. Freeman,et al.  ARE HOSPITAL SERVICES RATIONED IN NEW HAVEN OR OVER-UTILISED IN BOSTON? , 1987, The Lancet.

[28]  How to read clinical journals: II. To learn about a diagnostic test. , 1981, Canadian Medical Association journal.

[29]  I. Olkin,et al.  Improving the quality of reporting of randomized controlled trials. The CONSORT statement. , 1996, JAMA.

[30]  R. Doughty,et al.  Measuring health-related quality of life. , 1999, The New Zealand medical journal.

[31]  José Maria Paganni,et al.  Evaluating the quality of medical care. , 1966, The Milbank Memorial Fund quarterly.

[32]  M. Barry,et al.  Measuring disease-specific health status in men with benign prostatic hyperplasia. Measurement Committee of The American Urological Association. , 1995, Medical care.

[33]  B E Hillner,et al.  Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision-analysis model. , 1991, The New England journal of medicine.

[34]  W. Roper,et al.  Effectiveness in Health Care , 1988 .

[35]  J. Ioannidis,et al.  Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. , 2001, JAMA.

[36]  Relman As,et al.  Assessment and accountability: the third revolution in medical care. , 1988 .

[37]  J. Kassirer,et al.  Decision analysis: a progress report. , 1987, Annals of internal medicine.

[38]  L. Iezzoni.  Assessing Quality Using Administrative Data , 1997, Annals of Internal Medicine.

[39]  C J McDonald,et al.  A Framework for Capturing Clinical Data Sets from Computerized Sources , 1997, Annals of Internal Medicine.

[40]  A. Gittelsohn,et al.  Variations in medical care among small areas. , 1982, Scientific American.

[41]  D. Hutton,et al.  Cost-Effectiveness of Radiofrequency Ablation for Supraventricular Tachycardia , 2000, Annals of Internal Medicine.

[42]  A. Detsky,et al.  A clinician's guide to cost-effectiveness analysis. , 1990, Annals of internal medicine.

[43]  N. Aaronson,et al.  A modular approach to quality-of-life assessment in cancer clinical trials. , 1988, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[44]  S. Bolsin.  Professional misconduct: the Bristol case , 1998, The Medical journal of Australia.

[45]  P. Davey,et al.  A critical review of health-related economic evaluations in Australia: implications for health policy. , 1995, Health policy.

[46]  C. Clancy,et al.  Outcomes Research: Measuring the End Results of Health Care , 1998, Science.

[47]  C. Begg,et al.  Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results--Medicare. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  M. Barry,et al.  Patient Reactions to a Program Designed to Facilitate Patient Participation in Treatment Decisions for Benign Prostatic Hyperplasia , 1995, Medical care.

[49]  P. Clifford,et al.  Small-area variations in the use of common surgical procedures: an international comparison of New England, England, and Norway. , 1982, The New England journal of medicine.

[50]  J. Simes,et al.  Long-term Assessment of Psychological Well-being in a Randomized Placebo-Controlled Trial of Cholesterol Reduction With Pravastatin , 2000 .

[51]  M. Stockler,et al.  Resource implications of palliative chemotherapy for ovarian cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  B. Barnes,et al.  Professional uncertainty and the problem of supplier-induced demand. , 1982, Social science & medicine.

[53]  A. Willner,et al.  Problems in measurement and evaluation of rehabilitation. , 1962, Archives of physical medicine and rehabilitation.